Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Jul;72(1):237–244. doi: 10.1172/JCI110962

Interferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell lines.

T Hattori, M Pack, P Bougnoux, Z L Chang, T Hoffman
PMCID: PMC1129178  PMID: 6348086

Abstract

Effects of human fibroblast (beta) or leukocyte (alpha) interferon (IFN) on differentiations of a human histiocytic lymphoma-derived cell line (U937) or promyelocytic leukemia-derived cell line (HL-60) were studied. When cultured with beta-IFN (400-1,000 U/ml), U937 cells showed gross morphologic and microscopic changes consisting of clumping, increased cytoplasmic-to-nuclear ratio, enhanced prominence of cytoplasmic granules, and membrane ruffling. After culture with beta-IFN, the number of U937 cells reactive with B43.4.1 monoclonal antibody, which is specific for human monocytes, natural killer cells, and neutrophils, increased from less than 10% of U937 cells to 47% beta-IFN treatment also enhanced antibody-dependent cellular cytotoxicity against chicken erythrocytes by U937 cells. The same morphologic, phenotypic, and functional changes were also observed when U937 were treated with recombinant or natural alpha-IFN. The effects of alpha-IFN were totally abolished by anti-alpha-IFN serum. In contrast, HL-60, which differentiates toward cells of the monocyte lineage in response to phorbol 12-myristate 13-acetate (based on the above criteria), and toward granulocytes in response to dimethyl sulfoxide, did not differentiate when cultured with alpha- or beta-IFN. No consistent relationship between induction of differentiation and changes in phospholipid methylation were observed.

Full text

PDF
237

Images in this article

240FIGURE 2
on p.240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomgren H., Cantell K., Johansson B., Lagergren C., Ringborg U., Strander H. Interferon therapy in Hodgkin's disease. A case report. Acta Med Scand. 1976;199(6):527–532. doi: 10.1111/j.0954-6820.1976.tb06776.x. [DOI] [PubMed] [Google Scholar]
  2. Bougnoux P., Bonvini E., Chang Z. L., Hoffman T. Effect of interferon on phospholipid methylation by peripheral blood mononuclear cells. J Cell Biochem. 1982;20(3):215–223. doi: 10.1002/jcb.240200302. [DOI] [PubMed] [Google Scholar]
  3. Bougnoux P., Bonvini E., Stevenson H. C., Markey S., Zatz M., Hoffman T. Identification of ubiquinone-50 as the major methylated nonpolar lipid in human monocytes. Regulation of its biosynthesis via methionine-dependent pathways and relationship to superoxide production. J Biol Chem. 1983 Apr 10;258(7):4339–4344. [PubMed] [Google Scholar]
  4. Cassileth P. A., Suholet D., Cooper R. A. Early changes in phosphatidylcholine metabolism in human acute promyelocytic leukemia cells stimulated to differentiate by phorbol ester. Blood. 1981 Aug;58(2):237–243. [PubMed] [Google Scholar]
  5. Choi Y. S., Lim K. H., Sanders F. K. Effect of interferon alpha on pokeweed mitogen-induced differentiation of human peripheral blood b lymphocytes. Cell Immunol. 1981 Oct;64(1):20–28. doi: 10.1016/0008-8749(81)90454-8. [DOI] [PubMed] [Google Scholar]
  6. Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
  7. Diamond L., O'Brien T. G., Rovera G. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters. Nature. 1977 Sep 15;269(5625):247–249. doi: 10.1038/269247a0. [DOI] [PubMed] [Google Scholar]
  8. Dolei A., Colletta G., Capobianchi M. R., Rossi G. B., Vecchio G. Interferon effects on Friend leukaemia cells. I. EXpression of virus and erythroid markers in untreated and dimethyl sulphoxide-treated cells. J Gen Virol. 1980 Jan;46(1):227–236. doi: 10.1099/0022-1317-46-1-227. [DOI] [PubMed] [Google Scholar]
  9. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilcek J. Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2185–2187. doi: 10.1073/pnas.72.6.2185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirata F., Axelrod J. Phospholipid methylation and biological signal transmission. Science. 1980 Sep 5;209(4461):1082–1090. doi: 10.1126/science.6157192. [DOI] [PubMed] [Google Scholar]
  11. Hoffman T., Hirata F., Bougnoux P., Fraser B. A., Goldfarb R. H., Herberman R. B., Axelrod J. Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3839–3843. doi: 10.1073/pnas.78.6.3839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hoffman T. Natural killer funciton in systemic lupus erythematosus. Arthritis Rheum. 1980 Jan;23(1):30–35. doi: 10.1002/art.1780230106. [DOI] [PubMed] [Google Scholar]
  13. Honma Y., Kasukabe T., Hozumi M. Decrease in phospholipid methylation during differentiation of cultured mouse myeloid leukemia cells. Biochim Biophys Acta. 1981 May 22;664(2):441–444. [PubMed] [Google Scholar]
  14. Keay S., Grossberg S. E. Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4099–4103. doi: 10.1073/pnas.77.7.4099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Keisari Y., Pick E. Macrophage-mediated cytolysis off erythrocytes in the guinea pig. I. Activation by stimulators of the oxidative burst. Cell Immunol. 1981 Jul 15;62(1):172–185. doi: 10.1016/0008-8749(81)90311-7. [DOI] [PubMed] [Google Scholar]
  16. Kerr I. M., Brown R. E., Hovanessian A. G. Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature. 1977 Aug 11;268(5620):540–542. doi: 10.1038/268540a0. [DOI] [PubMed] [Google Scholar]
  17. Koren H. S., Anderson S. J., Larrick J. W. In vitro activation of a human macrophage-like cell line. Nature. 1979 May 24;279(5711):328–331. doi: 10.1038/279328a0. [DOI] [PubMed] [Google Scholar]
  18. Lee S. H., Epstein L. B. Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol. 1980 Mar 1;50(1):177–190. doi: 10.1016/0008-8749(80)90016-7. [DOI] [PubMed] [Google Scholar]
  19. Ling N. R., Bishop S., Jefferis Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins. J Immunol Methods. 1977;15(3):279–289. doi: 10.1016/0022-1759(77)90065-5. [DOI] [PubMed] [Google Scholar]
  20. Lotem J., Sachs L. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5158–5162. doi: 10.1073/pnas.76.10.5158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  22. Perussia B., Trinchieri G., Lebman D., Jankiewicz J., Lange B., Rovera G. Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells. Blood. 1982 Feb;59(2):382–392. [PubMed] [Google Scholar]
  23. Pike M. C., Fischer D. G., Koren H. S., Snyderman R. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines. J Exp Med. 1980 Jul 1;152(1):31–40. doi: 10.1084/jem.152.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rossi G. B., Dolei A., Cioé L., Benedetto A., Matarese G. P., Belardelli F. Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon. Proc Natl Acad Sci U S A. 1977 May;74(5):2036–2040. doi: 10.1073/pnas.74.5.2036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rovera G., O'Brien T. G., Diamond L. Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2894–2898. doi: 10.1073/pnas.74.7.2894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rovera G., Santoli D., Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2779–2783. doi: 10.1073/pnas.76.6.2779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sieber F., Stuart R. K., Spivak J. L. Tumor-promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow cells. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4402–4406. doi: 10.1073/pnas.78.7.4402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Staehelin T., Hobbs D. S., Kung H., Lai C. Y., Pestka S. Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J Biol Chem. 1981 Sep 25;256(18):9750–9754. [PubMed] [Google Scholar]
  29. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  30. Vogel S. N., Weedon L. L., Moore R. N., Rosenstreich D. L. Correction of defective macrophage differentiation in C3H/HeJ mice by an interferon-like molecule. J Immunol. 1982 Jan;128(1):380–387. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES